CONSUMER PROTECTION
In the fall of 1982, seven people were found dead in the Chicago area form cyanide in Extra-Strength Tylenol capsules. The bottles which contained the capsules had different lot numbers and came from different plants, ruling out the possible of employee tampering on the production line. Rather, they theorized tampering after they reached retail shelves. Johnson & Johnson immediately recalled 93,400 bottles after authorities theorized that the killer drove along Route 53, turning off at randomly selected points to place a poisoned bottle of capsules in each store.
Soon thereafter, the Food and Drug Administration met to draft tamper-resistant packaging that went into effect on February 7, 1983.
Damage to Johnson & Johnson was substantial. Consumer confidence in Tylenol fell and eventually 31 million bottles of Tylenol were recalled nationwide at a cost of $50 million after taxes. Eventually, consumer confidence was regained with new packages and the company’s image was enhanced by the way it handled the incident.
The FTC has 5 commissioners and is organized into three Bureaus, including the Bureau of Consumer Protection. The FTC has swung from being inactive prior to "Nader’s Raiders" to increased activism beginning in the 70s. In late 1970s congress was concerned over excessive FTC consumer action and began to talk about the legislative veto. The Veto was use by congress in 1982 to overturn the FTC rule requiring used car defects to be attached on a sticker for each car. (Later the Supreme Court found the Legislative Veto unconstitutional.) The activist era ended with Ronald Reagan’s presidency. In the 1990s the FTC has again become more active, especially regarding claims in advertising.
3. The Food and Drug Administration protects the public against impure and unsafe foods, drugs, and cosmetics and regulates hazards involving medical devices and radiation. The FDA also has responsibility for specific consumer legislation such as the Fair Packaging and Labeling Act.
The FDA regulates new drugs, requiring a thorough assessment by teams of physicians, pharmacists, chemists and statisticians from the Bureau of Drugs within the agency.
Medical devices must be approved before sale on the market. The composition, quality, nutrition, and safety of foods and food additives must also be approved, including any food additive that is found to cause cancer in animals as well as humans. In 1991, after a lassiz faire period during the 80s, the agency was revived by a new commissioner who planned aggressive enforcement of FDA regulations in several areas, including a high profile assault on food labeling. The commissioner also attacked the drug industry for questionable advertising and promotion.
Recently, a federal court ruled that FDA regulation of tobacco was not justified on the basis of nicotine being a drug.
CONSUMER ISSUES
Amendments to the Delaney Clause that introduce "significant risk" into the decision making process, allow a team of scientist to evaluate the potential toxic risk of additives under normal circumstances.
What standards of safety should apply and what risk levels should be accepted? Use of Alar in pesticides may cause one case of cancer for every 4,200 preschoolers, 240 times the acceptable standard. 60 Minutes and Meryl Streep resulted in apples being removed from school cafeterias in New York City, Los Angeles, and Chicago, with other cities following suit. Alar-free apples were advertised, but the state of Washington where 50 percent of the nation’s apples are grown loss $100 million in revenues.
In the early 1990s bioengineered foods began to appear on the market. Sweeter tomatoes, longer-lasting peppers, leaner pork, and healthier cooking oils were the result of biotech industry. In general, the FDA must approve all plant generated products, but not biotech foods involving meats, poultry, fish, or dairy products.
The drug approval process proceeds in three phases. Phase I tests the drug for toxicity and determines how it is metabolized in the body. Phase II is a controlled trial to from 50 to 200 subjects. Phase III studies its effects on 200 to several thousands subjects.
Foreign countries approve drugs much faster than in this country. Critics of regulation in this country say that American consumers are denied health advantages and benefits of new research. Proposals are continually being made to speed up the process to approve breakthrough drugs in the case of severe, life-threatening illnesses. Proposals include relying more on foreign data and contracting with private medical staff.
Approval of AZT to treat AIDS was obtained much earlier than usual because the FDA worked with company researchers on the projected. New drugs are likely to treat cancer, Alzheimer’s, Parkinson’s, arthritis, etc. that could benefit from the same process.
Based upon the standard statistical decision making network, a type 2 error of accepting a drug that is harmful takes priority over a type 1 error of rejecting a new drug that is effective. Reporting schemes are more likely to document the harmful side effects of drugs than the positive beneficial effects of their use.
The Justice Department has been involved with the controversy over the use of generic drugs after the 17-year patent on a brand-name product has expired. There has been a very competitive market for their approval and use that has led to some evidence that FDA chemists were paid off to gain faster approval of generic products that falsified laboratory test results. The result was more regulation on generic drug approval that makes it difficult for small firms to enter the market and smaller cost savings to consumers.
The first million dollar jury award occurred in 1962, while 401 such awards were offered in 1984 alone. The average verdict in product liability cases now tops $1 million. Ten juries handed out awards of over $25 million in 1989, reaching a high of $76 million to two workers that were exposed to asbestos. In 1993, a $105.2 million award in compensatory and punitive damages was assessed against General Motors after the death of a teenager whose pickup truck burst into flames after a crash. (The truck had outside-mounted gas tanks.)
The liability crisis has not abated, as juries award compensation for nonquantifiables, such as pain and suffering, and punitive damages that go far beyond actual damages. Many manufacturers have been forced to abandon products and markets they spent years in developing. Prices have been increased and product innovation reduced. The aviation industry produced only 1,085 aircraft in 1987, compared with 17,000 in 1979. The average cost of product liability coverage for each aircraft reached $70,000 compared with $51 in 1962. A surcharge to cover the cost of liability insurance on new planes by Beech and Cessna resulted in prices that could not compete with used planes on the market.
A theory based upon "reasonable person" negligence and limits to punitive damages would offer a replacement of "strict liability" theories that holds the producer or seller responsible for damages if a consumer is injured as a result of a product defect regardless of the degree of care exercised by the consumer. The Supreme Court has had several opportunities to place limits on punitive damages, but has been unable to find a constitutional foundation. Businesses have appealed for federal legislation to provide such limits. The liability crisis is particularly acute in the health care industry and has added to a movement toward tort reform that would place limits on damages in an effort to reduce health care costs.
Business organizations, the insurance industry, the medical profession, and assorted groups of educators and public officials favor limits, while personal injury lawyers, labor unions, and consumer and environmental groups oppose limits. Congress has been unable to pass legislation due to the opposition. Production liability will thus continue to be a major management problem that will require additional attention regarding warnings about using products, quality control systems to eliminate defects, and product design to eliminate hazards. Companies are adopting self-insurance strategies to avoid paperwork with insurance companies.
Tort law is likely to remain a principal method of redistributing resources away from active economic producers to passive "victims" of the economic system, just as the welfare system that was expanded during the 60s and the actions of regulatory agencies that were expanded during the 70s have done in the past.